Smith Group Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-700
| Closed | -$22K | – | 395 |
|
|
2021
Q2 | $22K | Hold |
700
| – | – | ﹤0.01% | 226 |
|
|
2021
Q1 | $18K | Sell |
700
-31,368
| -98% | -$807K | ﹤0.01% | 224 |
|
|
2020
Q4 | $807K | Sell |
32,068
-5,730
| -15% | -$144K | 0.05% | 109 |
|
|
2020
Q3 | $788K | Sell |
37,798
-10
| -0% | -$208 | 0.04% | 111 |
|
|
2020
Q2 | $898K | Buy |
+37,808
| New | +$898K | 0.05% | 106 |
|
|
2019
Q4 | – | Sell |
-15,627
| Closed | -$429K | – | 405 |
|
|
2019
Q3 | $429K | Sell |
15,627
-400
| -2% | -$11K | 0.02% | 156 |
|
|
2019
Q2 | $530K | Sell |
16,027
-339
| -2% | -$11.2K | 0.02% | 148 |
|
|
2019
Q1 | $573K | Sell |
16,366
-211
| -1% | -$7.39K | 0.02% | 157 |
|
|
2018
Q4 | $551K | Sell |
16,577
-4
| -0% | -$133 | 0.02% | 188 |
|
|
2018
Q3 | $835K | Sell |
16,581
-42,940
| -72% | -$2.16M | 0.02% | 181 |
|
|
2018
Q2 | $3.56M | Buy |
59,521
+1,950
| +3% | +$117K | 0.1% | 98 |
|
|
2018
Q1 | $2.64M | Buy |
57,571
+12,009
| +26% | +$550K | 0.09% | 107 |
|
|
2017
Q4 | $1.82M | Sell |
45,562
-15,805
| -26% | -$630K | 0.06% | 151 |
|
|
2017
Q3 | $2.46M | Sell |
61,367
-10,762
| -15% | -$431K | 0.08% | 141 |
|
|
2017
Q2 | $3.11M | Sell |
72,129
-56,391
| -44% | -$2.43M | 0.1% | 133 |
|
|
2017
Q1 | $4.02M | Sell |
128,520
-3,451
| -3% | -$108K | 0.12% | 111 |
|
|
2016
Q4 | $3.33M | Sell |
131,971
-50,820
| -28% | -$1.28M | 0.1% | 119 |
|
|
2016
Q3 | $4.52M | Sell |
182,791
-20,822
| -10% | -$515K | 0.13% | 96 |
|
|
2016
Q2 | $4.15M | Sell |
203,613
-29,979
| -13% | -$611K | 0.12% | 97 |
|
|
2016
Q1 | $3.56M | Buy |
233,592
+232,380
| +19,173% | +$3.54M | 0.11% | 97 |
|
|
2015
Q4 | $16K | Buy |
+1,212
| New | +$16K | ﹤0.01% | 409 |
|